Market Overview

UPDATE: Morgan Stanley Initiates Coverage On Intuitive Surgical

Related ISRG
Bank Of America Raises Intuitive Surgical Price Target
Intuitive Surgical Reports New Employee Option Grants for December 2014
Stocks Sell Off as Shift from Risk Persists (Fox Business)

In a report released Wednesday, Morgan Stanley analyst David Lewis initiated coverage on Intuitive Surgical (NASDAQ: ISRG) with a base case of $370. Morgan Stanley previously had an Overweight rating.

Analysts at Morgan Stanley believe Intuitive Surgical's improved procedures will result in a short run investor relief rally, but they don't see proof of inflection. Lewis claimed Intuitive Surgical's ability to manage stock-comp is out of range compared to its peers.

Morgan Stanley is prevented from calling an inflection due to system utilization rates continuing to be in negative territory year-over-year. This indicates underlying demand for new systems, comps uncertainty from its recovery to decline and net system payments decline quarter-over-quarter.

Morgan Stanley's base case of $370 per share was given by a 25x multiple from its 2015 estimate of $14.78.

Latest Ratings for ISRG

DateFirmActionFromTo
Oct 2014Northland SecuritiesUpgradesUnderperformMarket Perform
Oct 2014BTIG ResearchUpgradesNeutralBuy
Oct 2014Leerink SwannUpgradesMarket PerformOutperform

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: David Lewis Morgan StanleyAnalyst Color Initiation Analyst Ratings

 

Related Articles (ISRG)

Around the Web, We're Loving...

Get Benzinga's Newsletters